| PAX5 |
PAX5: Paired box protein Pax-5 |
CDX2 |
CDX2, CDX3: Homeobox protein CDX-2 |
2.63 |
Evidence |
|
| FSTL3 |
FSTL3, FLRG, UNQ674/PRO1308: Follistatin-related protein 3 precursor |
INHBB |
INHBB: Inhibin beta B chain precursor |
2.63 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
MTMR3 |
MTMR3, KIAA0371, ZFYVE10: Myotubularin-related protein 3 |
2.63 |
Evidence |
|
| PEX7 |
PEX7, PTS2R: Peroxisomal targeting signal 2 receptor |
TAF12 |
TAF12, TAF15, TAF2J, TAFII20: Transcription initiation factor TFIID subunit 12 |
2.63 |
Evidence |
|
| MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
MTMR3 |
MTMR3, KIAA0371, ZFYVE10: Myotubularin-related protein 3 |
2.63 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
HYAL2 |
HYAL2, LUCA2: Hyaluronidase-2 precursor |
2.63 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
SHC2 |
IPI00401979 |
2.622 |
Evidence |
|
| ASCL2 |
ASCL2: Achaete-scute homolog 2 |
TCFL5 |
TCFL5, CHA, E2BP1: Transcription factor-like 5 protein |
2.622 |
Evidence |
|
| KCNQ3 |
KCNQ3: Potassium voltage-gated channel subfamily KQT member 3 |
TRPC1 |
TRPC1, TRP1: Short transient receptor potential channel 1 |
2.622 |
Evidence |
|
| DEDD2 |
DEDD2, FLAME3, PSEC0004: DNA-binding death effector domain-containing protein 2 |
CARD9 |
IPI00072229 |
2.622 |
Evidence |
|
| HRK |
HRK, BID3: Activator of apoptosis harakiri |
BCL2L12 |
BCL2L12, BPR: Bcl-2-related proline-rich protein |
2.622 |
Evidence |
|
| TCF3 |
IPI00216911 |
BHLHB8 |
BHLHB8, MIST1: Class B basic helix-loop-helix protein 8 |
2.622 |
Evidence |
|
| CACNA1C |
CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1: Voltage-dependent L-type calcium chann |
HCN4 |
HCN4: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated chann |
2.622 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-81 alpha chain precursor |
2.622 |
Evidence |
|
| BID |
BID: BH3-interacting domain death agonist |
BBC3 |
BBC3, PUMA: Bcl-2-binding component 3 |
2.622 |
Evidence |
|
| TRPC6 |
TRPC6, TRP6: Short transient receptor potential channel 6 |
MFN1 |
MFN1: Mitofusin-1 |
2.622 |
Evidence |
|
| TRPA1 |
TRPA1, ANKTM1: Transient receptor potential cation channel subfamily A member 1 |
CACNA1F |
CACNA1F: Uncharacterized protein CACNA1F |
2.622 |
Evidence |
|
| CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
HLA-C |
HLA-C, D6S204, HLA-JY3, HLAC: HLA class I histocompatibility antigen, Cw-17 alph |
2.622 |
Evidence |
|
| BMF |
BMF: Bcl-2-modifying factor |
BBC3 |
BBC3, PUMA: Bcl-2-binding component 3 |
2.622 |
Evidence |
|
| BCL2L11 |
BCL2L11, BIM: Bcl-2-like protein 11 |
BBC3 |
BBC3, PUMA: Bcl-2-binding component 3 |
2.622 |
Evidence |
|
| NULL |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-18 alpha chain precursor |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
2.622 |
Evidence |
|
| TCF3 |
IPI00216911 |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
2.622 |
Evidence |
|
| SIM1 |
SIM1: Single-minded homolog 1 |
SIM2 |
SIM2: Single-minded homolog 2 |
2.622 |
Evidence |
|
| NFKB1 |
IPI00292537 |
CARD11 |
CARD11, CARMA1: Caspase recruitment domain-containing protein 11 |
2.622 |
Evidence |
|
| ELA3B |
ELA3B: Elastase-3B precursor |
SERPINB11 |
SERPINB11: Serpin B11 |
2.622 |
Evidence |
|